Publications-Scopus引用排序

Showing 1-24 of 24

Date Title Type  Full Text Scopus▼ WOS
2013.01 Magnolia Polyphenols Attenuate Oxidative and Inflammatory Responses in Neurons and Microglial Cells article (1101) 61 無資料
2009.1 Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain article (1458) 43 無資料
2017 Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels article (638) 31 無資料
2011.02 mGluR5 positive modulators both potentiate activation and restore inhibition in NMDA receptors by PKC dependent pathway article (871) 24 無資料
2012.01 Honokiol Suppresses the Development of Post-ischemic Glucose Intolerance and Neuronal Damage in Mice article (1198) 22 無資料
2012.04 Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine. article (846) 21 無資料
2016-05 Resveratrol attenuates cortical neuron activity: roles of large conductance calcium-activated potassium channels and voltage-gated sodium channels article (374) 17 無資料
2014-10 Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice article (783) 17 無資料
2015-03 Protective role of L-ascorbic acid, N-acetylcysteine and apocynin on neomycin-induced hair cell loss in Zebrafish article (758) 16 無資料
2016-11 N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice article (298) 12 無資料
2016-09 Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice article (419) 10 無資料
2018 Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson’s disease article (321) 9 無資料
2018-08 Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson’s disease article (235) 9 無資料
2017 Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials article (562) 9 無資料
2017-03 Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo18 F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging article (342) 7 無資料
2017-03 Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging. article (312) 7 無資料
2018-12 Therapeutic effects of honokiol on motor impairment in hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPARr regulation article (218) 6 無資料
2013.02 Honokiol Blocks Store Operated Calcium Entry in CHO Cells Expressing the M3 Muscarinic Receptor: Honokiol and Muscarinic Signaling article (1017) 6 無資料
2013.11 Methamphetamine inhibits voltage-gated potassium currents in NG108-15 cells: Possible contribution of large-conductance calcium-activated potassium channels article (1181) 5 無資料
2018 Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine article (548) 4 無資料
2015-06 The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances article (709) 3 無資料
2018-09 Attenuation of toluene-induced brain stimulation reward enhancement and behavioral disturbances by N-acetylcysteine in mice article (316) 3 無資料
2017-12 Effect of Pachybasin on General Toxicity and Developmental Toxicity in Vivo article (556) 3 無資料
2018-08 Lamotrigine attenuates the motivation to self-administer ketamine and prevents cue- and prime-induced reinstatement of ketamine-seeking behavior in rats article (197) 0 無資料